Reversing dabigatran in life-threat- ening bleeding occurring during cardiac ablation with factor eight inhibi- tor bypassing activity. Crit Care Med. 2013;41:e42 e46. doi: 10.1097/ CCM.0b013e31827caaa3. 97. Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Reversal of rivaroxaban and dabigatran by prothrombin com- plex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation. 2011;124:1573 1579. doi: 10.1161/ CIRCULATIONAHA.111.029017. 98. Lazo-Langner A, Lang ES, Douketis J. Clinical review: clinical man- agement of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications. Crit Care. 2013;17:230. doi: 10.1186/cc12592. 99. Oh JJ, Akers WS, Lewis D, Ramaiah C, Flynn JD. Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to antico- agulation with the direct thrombin inhibitor lepirudin. Pharmacotherapy. 2006;26:569 577. doi: 10.1592/phco.26.4.576. 100. Kaatz S, Kouides PA, Garcia DA, Spyropolous AC, Crowther M, Douketis JD, Chan AK, James A, Moll S, Ortel TL, Van Cott EM, Ansell J. Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. Am J Hematol. 2012;87 Suppl 1:S141 S145. doi: 10.1002/ ajh.23202. 101. Majeed A, Schulman S. Bleeding and antidotes in new oral anticoagu- lants. Best Pract Res Clin Haematol. 2013;26:191 202. doi: 10.1016/j. beha.2013.07.001. 102. Sansing LH, Messe SR, Cucchiara BL, Cohen SN, Lyden PD, Kasner SE; CHANT Investigators. Prior antiplatelet use does not affect hem- orrhage growth or outcome after ICH. Neurology. 2009;72:1397 1402. doi: 10.1212/01.wnl.0000342709.31341.88. 103. Naidech AM, Jovanovic B, Liebling S, Garg RK, Bassin SL, Bendok BR, Bernstein RA, Alberts MJ, Batjer HH. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke. 2009;40:2398 2401. doi: 10.1161/ STROKEAHA.109.550939. 104. Naidech AM, Bernstein RA, Levasseur K, Bassin SL, Bendok BR, Batjer HH, Bleck TP, Alberts MJ. Platelet activity and outcome after intracerebral hemorrhage. Ann Neurol. 